Reported Standalone quarterly numbers for Contech Software are: Net Sales at Rs 2.32 crore in September 2024 down 43.42% from Rs. 4.10 crore in September 2023. Quarterly Net Profit at Rs. 0.42 crore in September 2024 up 41.94% from Rs. 0.29 crore in September 2023. EBITDA stands at Rs. 0.56 crore in September 2024 up 60% from Rs. 0.35 crore in September 2023.

Reported Standalone quarterly numbers for GEE are: Net Sales at Rs 82.83 crore in September 2024 down 15.04% from Rs. 97.49 crore in September 2023. Quarterly Net Profit at Rs. 1.91 crore in September 2024 down 64.63% from Rs. 5.40 crore in September 2023. EBITDA stands at Rs. 5.81 crore in September 2024 down 41.25% from Rs. 9.89 crore in September 2023.

Reported Standalone quarterly numbers for Bartronics India are: Net Sales at Rs 8.85 crore in September 2024 down 28.79% from Rs. 12.43 crore in September 2023. Quarterly Net Profit at Rs. 0.25 crore in September 2024 up 125.1% from Rs. 0.99 crore in September 2023. EBITDA stands at Rs. 0.26 crore in September 2024 up 204% from Rs. 0.25 crore in September 2023.

Reported Standalone quarterly numbers for Godavari Drugs are: Net Sales at Rs 26.09 crore in September 2024 down 34.03% from Rs. 39.54 crore in September 2023. Quarterly Net Profit at Rs. 1.09 crore in September 2024 up 27.2% from Rs. 0.86 crore in September 2023. EBITDA stands at Rs. 2.91 crore in September 2024 down 4.9% from Rs. 3.06 crore in September 2023.

Reported Standalone quarterly numbers for Kerala Ayurveda are: Net Sales at Rs 20.03 crore in September 2024 up 6.87% from Rs. 18.75 crore in September 2023. Quarterly Net Loss at Rs. 0.54 crore in September 2024 down 205.96% from Rs. 0.51 crore in September 2023. EBITDA stands negative at Rs. 0.16 crore in September 2024 down 120.51% from Rs. 0.78 crore in September 2023.

Gujarat Toolroom Limited's share price surged 4.99% to ₹13.26 after securing a ₹310 million order from Reliance Industries, marking a key milestone in their partnership, with the company expressing optimism for additional orders and having raised ₹50 crore via a Qualified Institutional Placement earlier this year.

Reported Standalone quarterly numbers for Smruthi Organics Limited are: Net Sales at Rs 29.39 crore in September 2024 down 0.68% from Rs. 29.59 crore in September 2023. Quarterly Net Profit at Rs. 0.78 crore in September 2024 down 62.55% from Rs. 2.07 crore in September 2023. EBITDA stands at Rs. 2.90 crore in September 2024 down 34.68% from Rs. 4.44 crore in September 2023.

Reported Standalone quarterly numbers for Desh Rakshak Aushadalaya are: Net Sales at Rs 1.19 crore in September 2024 up 42.33% from Rs. 0.84 crore in September 2023. Quarterly Net Profit at Rs. 0.15 crore in September 2024 up 61.06% from Rs. 0.09 crore in September 2023. EBITDA stands at Rs. 0.33 crore in September 2024 up 3.13% from Rs. 0.32 crore in September 2023.

Reported Standalone quarterly numbers for Bal Pharma are: Net Sales at Rs 74.70 crore in September 2024 down 19.07% from Rs. 92.30 crore in September 2023. Quarterly Net Profit at Rs. 1.21 crore in September 2024 down 24.24% from Rs. 1.60 crore in September 2023. EBITDA stands at Rs. 7.84 crore in September 2024 down 2.85% from Rs. 8.07 crore in September 2023.

Reported Standalone quarterly numbers for Parmax Pharma are: Net Sales at Rs 9.28 crore in September 2024 up 128.05% from Rs. 4.07 crore in September 2023. Quarterly Net Loss at Rs. 0.22 crore in September 2024 up 84.14% from Rs. 1.37 crore in September 2023. EBITDA stands at Rs. 0.31 crore in September 2024 up 140.79% from Rs. 0.76 crore in September 2023.

BSE share price advanced over 4 percent in November 25 trade on introduction of futures and options (F&O) contracts for 43 stocks. The information was disclosed post market hours on November 22 by the exchange. BSE stock surged 4.5 percent to its intraday high of Rs 4,933 per share on the NSE. At around 12 pm, the stock quoted at Rs 4,845.70 apiece, up 2.66 percent.

Reported Standalone quarterly numbers for Brawn Biotech are: Net Sales at Rs 3.30 crore in September 2024 up 12.95% from Rs. 2.92 crore in September 2023. Quarterly Net Loss at Rs. 0.34 crore in September 2024 up 18.67% from Rs. 0.42 crore in September 2023. EBITDA stands negative at Rs. 0.31 crore in September 2024 up 20.51% from Rs. 0.39 crore in September 2023.

ICICI Lombard General Insurance acquired a 0.19% stake in HDFC Life Insurance for ₹233 crore, increasing its presence in the life insurance market. ICICI Lombard reported a 20.2% net profit growth in Q2 FY25, driven by a 10.4% increase in Gross Direct Premium Income, outpacing the industry growth rate.

J Kumar Infra shares surge 16% to a 21-week high after the BJP-led alliance's win in the Maharashtra state elections, driven by optimism in infrastructure development, with analysts expecting a significant improvement in the capex cycle in the second half of the fiscal year, benefiting EPC firms like J Kumar Infra.

At around 10.24 AM, Zee Entertainment was trading 2.40% higher at ₹119.98, against the previous close of ₹117.17 on NSE. The counter touched an intraday high and low of ₹120.96, and ₹118.78, respectively. This happned post CEO, Punit Goenka, who resigned as managing director (MD) last week, has withdrawn his approval for re-appointment as MD, which was earlier suggested for approval at the AGM.